Products for Research Use Only
RegisterLogin

Risankizumab (anti-IL-23)

CAT: 1568-C00045-1mgSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1568-C00045-1mgSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1612838-76-2
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Related Products

CatalogName
C00241-01Guselkumab (Anti-IL-23)
C00702-1mg*5Mirikizumab (Anti-IL-23)
C00700-1mgBrazikumab (Anti-IL-23)
C00241-1mg*25Guselkumab (Anti-IL-23)
C00701-01Anti-IL-23 (LY2525623)
C00702-1mg*25Mirikizumab (Anti-IL-23)
C00700-1mg*25Brazikumab (Anti-IL-23)
C00700-1mg*5Brazikumab (Anti-IL-23)
C00700-01Brazikumab (Anti-IL-23)
C00702-01Mirikizumab (Anti-IL-23)

Alternative Products

CatalogName
A2046-5mgRisankizumab (anti-IL-23)
B22457001-01V6 Anti-Human IL-23α (Risankizumab)
F1241-.1Anti-IL-23a Antibody (Risankizumab)
M01097-2Anti-IL-23a Reference Antibody (risankizumab)
GTR18622495-01Anti-human IL-23a (Risankizumab Biosimilar)
NBP3-28777CL1Human Monoclonal IL-23A/IL-23 P19 Antibody (risankizumab) [CoraFluor 1]
047647IL-23a (risankizumab) discontinued
NBP3-28777JF669Human Monoclonal IL-23A/IL-23 P19 Antibody (risankizumab) [Janelia Fluor 669]
NBP3-28777JF635Human Monoclonal IL-23A/IL-23 P19 Antibody (risankizumab) [Janelia Fluor 635]
NBP3-28777-100ugCHO Monoclonal IL-23A/IL-23 P19 Antibody (risankizumab) - Humanized - (Dry Ice)

Popular Products